Skip to main content
. 2020 Mar 9;13:2021–2030. doi: 10.2147/OTT.S232453

Figure 5.

Figure 5

Differences in expression levels of exosomal miRNA-122 (A), miRNA-21 (B), miRNA-96 (C) and miRNA panel (D) could influence the patients’ progression-free survival time.